Table with 6 columns and 5 rows.
US11981733B214 May 2024GrantUS17478497Lag-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereofJiangsu Hengrui Medicine Co Ltd; Shanghai Hengrui Pharmaceuticals Co Ltd
US11866500B29 January 2024GrantUS17454634Use of combination of anti-pd-1 antibody and vegfr inhibitor in preparation of drug for treating cancersShanghai Hengrui Pharmaceuticals Co Ltd; Suzhou Suncadia Biopharmaceuticals Co Ltd; Jiangsu Hengrui Medicine Co Ltd
US11780923B210 October 2023GrantUS16947583Pd-l1 antibody, antigen-binding fragment thereof and medical application thereofSuzhou Suncadia Biopharmaceuticals Co Ltd; Jiangsu Hengrui Medicine Co Ltd; Shanghai Hengrui Pharmaceuticals Co Ltd
US11717559B28 August 2023GrantUS17129100Interleukin 15 protein complex and use thereofJiangsu Hengrui Medicine Co Ltd; Shanghai Hengrui Pharmaceuticals Co Ltd
US11701349B218 July 2023GrantUS16757363Pharmaceutical composition containing quinoline derivativeJiangsu Hengrui Medicine Co Ltd
GlobalData